Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18878968
[patent_doc_number] => 20240002337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE
[patent_app_type] => utility
[patent_app_number] => 17/988753
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988753 | SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE | Nov 15, 2022 | |
Array
(
[id] => 18657582
[patent_doc_number] => 20230303489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/982187
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982187 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nov 6, 2022 | Pending |
Array
(
[id] => 18567070
[patent_doc_number] => 20230257399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => IRAK4 DEGRADERS AND SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/050883
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050883 | IRAK4 DEGRADERS AND SYNTHESIS THEREOF | Oct 27, 2022 | Pending |
Array
(
[id] => 18284739
[patent_doc_number] => 20230100211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
[patent_app_type] => utility
[patent_app_number] => 17/972008
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972008 | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) | Oct 23, 2022 | Pending |
Array
(
[id] => 18980137
[patent_doc_number] => 11905297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => OX2R compounds
[patent_app_type] => utility
[patent_app_number] => 17/971547
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 87
[patent_no_of_words] => 59919
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971547 | OX2R compounds | Oct 20, 2022 | Issued |
Array
(
[id] => 19425014
[patent_doc_number] => 12084415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent
[patent_app_type] => utility
[patent_app_number] => 17/970533
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 113
[patent_no_of_words] => 46047
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970533 | Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent | Oct 19, 2022 | Issued |
Array
(
[id] => 19060120
[patent_doc_number] => 11939328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Quinoline compounds as inhibitors of KRAS
[patent_app_type] => utility
[patent_app_number] => 18/046303
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77389
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046303 | Quinoline compounds as inhibitors of KRAS | Oct 12, 2022 | Issued |
Array
(
[id] => 18451408
[patent_doc_number] => 20230192686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/964423
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 710
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964423 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | Oct 11, 2022 | Pending |
Array
(
[id] => 18770807
[patent_doc_number] => 20230365605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/045647
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045647 | BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF | Oct 10, 2022 | Pending |
Array
(
[id] => 18657654
[patent_doc_number] => 20230303591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => RAS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/938890
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938890 | RAS INHIBITORS | Oct 6, 2022 | Pending |
Array
(
[id] => 18223981
[patent_doc_number] => 20230062975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HEPATITIS B CAPSID ASSEMBLY MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/947593
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947593 | HEPATITIS B CAPSID ASSEMBLY MODULATORS | Sep 18, 2022 | Abandoned |
Array
(
[id] => 18213745
[patent_doc_number] => 20230060011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/946587
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946587 | Antibacterial compounds | Sep 15, 2022 | Issued |
Array
(
[id] => 19226693
[patent_doc_number] => 12006326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Antiviral heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/894412
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50601
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894412 | Antiviral heterocyclic compounds | Aug 23, 2022 | Issued |
Array
(
[id] => 18253835
[patent_doc_number] => 20230080874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => TROPOMYOSIN-RELATED KINASE (trk) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/883350
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883350
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/883350 | Tropomyosin-related kinase (Trk) inhibitors | Aug 7, 2022 | Issued |
Array
(
[id] => 19311550
[patent_doc_number] => 12037353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Carbon capture, storage, and recycling compositions
[patent_app_type] => utility
[patent_app_number] => 17/861740
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 4167
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861740
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861740 | Carbon capture, storage, and recycling compositions | Jul 10, 2022 | Issued |
Array
(
[id] => 18312886
[patent_doc_number] => 20230116786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => 2-SUBSTITUTED AMINO-NAPHTH (1,2-D) IMIDAZOL-5-ONE COMPOUNDS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/862290
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862290 | 2-SUBSTITUTED AMINO-NAPHTH (1,2-D) IMIDAZOL-5-ONE COMPOUNDS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Jul 10, 2022 | Pending |
Array
(
[id] => 18209944
[patent_doc_number] => 20230056205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SUBSTITUTED 4,6-DIHYDROSPIRO[[1,2,3]TRIAZOLO[4,5-B]PYRIDINE-7,3'-INDOLINE]-2',5(3H)-DIONE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 17/856915
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856915 | Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues | Jun 30, 2022 | Issued |
Array
(
[id] => 18347784
[patent_doc_number] => 20230135894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MK2 DEGRADERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/855336
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855336 | MK2 DEGRADERS AND USES THEREOF | Jun 29, 2022 | Pending |
Array
(
[id] => 18213738
[patent_doc_number] => 20230060004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => DIACYLGLYERCOL KINASE MODULATING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/845469
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845469 | Diacylglycerol kinase modulating compounds | Jun 20, 2022 | Issued |
Array
(
[id] => 17882650
[patent_doc_number] => 20220298127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => BICYCLIC HETEROARYL DERIVATIVES AND PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/835106
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835106 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jun 7, 2022 | Issued |